Similar articles

• [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].

  Freyler H, Sehorst W. Freyler H, et al. Klin Monbl Augenheilkd. 1974 Feb;164(2):246-51. Klin Monbl Augenheilkd. 1974. PMID: 4842139 Clinical Trial. German. No abstract available.
• Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy.

  Freyler H. Freyler H. Ophthalmologica. 1974;168(5):400-16. doi: 10.1159/000307064. Ophthalmologica. 1974. PMID: 4598805 Clinical Trial. No abstract available.
• What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).

  Cuendet JF, Sevin R. Cuendet JF, et al. Bull Ophthalmol Soc Egypt. 1976;69(73):469-74. Bull Ophthalmol Soc Egypt. 1976. PMID: 1031108 No abstract available.
• [Calcium dobesilate].

  Reuter H. Reuter H. Z Allgemeinmed. 1975 Feb 28;51(6):292-3. Z Allgemeinmed. 1975. PMID: 1092080 Review. German. No abstract available.
• Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.

  Allain H, Ramelet AA, Polard E, Bentué-Ferrer D. Allain H, et al. Drug Saf. 2004;27(9):649-60. doi: 10.2165/00002018-200427090-00003. Drug Saf. 2004. PMID: 15230646 Review.